BR0016867A - Precursor de análogo de insulina, sequência de polinucleotìdeo, vetor de expressão, célula hospedeira, e, processos para fabricar um precursor de análogo de insulina e para fabricar um análogo de insulina - Google Patents
Precursor de análogo de insulina, sequência de polinucleotìdeo, vetor de expressão, célula hospedeira, e, processos para fabricar um precursor de análogo de insulina e para fabricar um análogo de insulinaInfo
- Publication number
- BR0016867A BR0016867A BR0016867-0A BR0016867A BR0016867A BR 0016867 A BR0016867 A BR 0016867A BR 0016867 A BR0016867 A BR 0016867A BR 0016867 A BR0016867 A BR 0016867A
- Authority
- BR
- Brazil
- Prior art keywords
- insulin analog
- precursor
- making
- insulin
- processes
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 13
- 239000002243 precursor Substances 0.000 title abstract 10
- 239000004026 insulin derivative Substances 0.000 title abstract 6
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 239000013604 expression vector Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 4
- 108090001061 Insulin Proteins 0.000 abstract 4
- 229940125396 insulin Drugs 0.000 abstract 4
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 108010075254 C-Peptide Proteins 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"PRECURSOR DE ANáLOGO DE INSULINA, SEQUêNCIA DE POLINUCLEOTìDEO VETOR DE EXPRESSãO, CéLULA HOSPEDEIRA, E, PROCESSOS PARA FABRICAR UM PRECURSOR DE ANáLOGO DE INSULINA E PARA FABRICAR UM ANáLOGO DE INSULINA". Novos precursores da insulina e análogos de precursor da insulina tendo um mini peptídeo C que compreende pelo menos um resíduo de aminoácido aromático têm uma estabilidade de dobra aumentada. Os novos precursores da insulina e análogos de precursor da insulina podem ser expressados em levedura em altos rendimentos e preferivelmente não têm mais do que 15 resíduos de aminoácido no comprimento. Também são fornecidas seq³ências de polinucleotídeo que codificam os precursores ou análogos de precursor reivindicados e vetores e linhas de célula contendo tais seq³ências de polinucleotídeo.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199901868 | 1999-12-29 | ||
DKPA200000440 | 2000-03-17 | ||
PCT/DK2000/000665 WO2001049742A1 (en) | 1999-12-29 | 2000-12-04 | Method for making insulin precursors and insulin precursor analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0016867A true BR0016867A (pt) | 2002-10-08 |
Family
ID=26066172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0016867-0A BR0016867A (pt) | 1999-12-29 | 2000-12-04 | Precursor de análogo de insulina, sequência de polinucleotìdeo, vetor de expressão, célula hospedeira, e, processos para fabricar um precursor de análogo de insulina e para fabricar um análogo de insulina |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1246845B1 (pt) |
JP (1) | JP4773023B2 (pt) |
KR (1) | KR20030004317A (pt) |
CN (1) | CN100432104C (pt) |
AT (1) | ATE397017T1 (pt) |
AU (1) | AU1850601A (pt) |
BR (1) | BR0016867A (pt) |
CA (1) | CA2392840C (pt) |
DE (1) | DE60039074D1 (pt) |
ES (1) | ES2307544T3 (pt) |
HU (1) | HUP0203475A3 (pt) |
RU (1) | RU2283846C2 (pt) |
WO (1) | WO2001049742A1 (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7105314B2 (en) | 2001-04-02 | 2006-09-12 | Novo Nordisk A/S | Method for making human insulin precursors |
WO2002079250A1 (en) * | 2001-04-02 | 2002-10-10 | Novo Nordisk A/S | Insulin precursors and a process for their preparation |
CA2464616C (en) | 2001-11-19 | 2012-07-24 | Are Bogsnes | Process for preparing insulin compounds |
WO2004085472A1 (en) * | 2003-03-27 | 2004-10-07 | Novo Nordisk A/S | Method for making human insulin precursors and human insulin |
WO2005054291A1 (en) * | 2003-12-03 | 2005-06-16 | Novo Nordisk A/S | Single-chain insulin |
CN100460508C (zh) * | 2004-11-03 | 2009-02-11 | 马延高 | 人胰岛素基因在甲醇酵母中的分泌表达方法 |
ES2558930T3 (es) | 2007-08-13 | 2016-02-09 | Novo Nordisk A/S | Análogos de la insulina de acción rápida |
JP5721432B2 (ja) | 2007-08-15 | 2015-05-20 | ノボ・ノルデイスク・エー/エス | アミノ酸含有アルキレングリコール反復単位を含むアシル部を有するインスリン |
WO2009022013A1 (en) | 2007-08-15 | 2009-02-19 | Novo Nordisk A/S | Insulin analogues with an acyl and aklylene glycol moiety |
ES2563553T3 (es) | 2008-04-01 | 2016-03-15 | Novo Nordisk A/S | Conjugados de insulina-albúmina |
US8815798B2 (en) | 2010-06-23 | 2014-08-26 | Novo Nordisk A/S | Insulin analogues containing additional disulfide bonds |
RU2598273C2 (ru) | 2010-06-23 | 2016-09-20 | Ново Нордиск А/С | Производные инсулина, содержащие дополнительные дисульфидные связи |
WO2011161083A1 (en) | 2010-06-23 | 2011-12-29 | Novo Nordisk A/S | Human insulin containing additional disulfide bonds |
WO2012171994A1 (en) | 2011-06-15 | 2012-12-20 | Novo Nordisk A/S | Multi substituted insulins |
RU2014127270A (ru) * | 2011-12-15 | 2016-02-10 | Шанхай Хэнжуй Фармасьютикал Ко., Лтд. | Аналог человеческого инсулина и его ацилированное производное |
JP2016521701A (ja) | 2013-06-07 | 2016-07-25 | ノヴォ ノルディスク アー/エス | 成熟インスリンポリペプチドを作製するための方法 |
CN105087724B (zh) * | 2014-05-04 | 2019-12-03 | 重庆派金生物科技有限公司 | 酵母重组表达门冬胰岛素的制备方法 |
CN107417787B (zh) * | 2016-05-23 | 2020-11-17 | 江苏恒瑞医药股份有限公司 | 一种人松弛素2类似物的制备方法 |
CN107446039B (zh) * | 2016-05-31 | 2021-11-12 | 江苏恒瑞医药股份有限公司 | 一种人胰岛素类似物前体及其制备方法 |
CN106699872B (zh) * | 2016-12-27 | 2019-12-24 | 江南大学 | 一种提高胰岛素前体产量的方法 |
MX2020001434A (es) | 2017-08-17 | 2020-03-20 | Novo Nordisk As | Analogos de insulina acilados novedosos y usos de estos. |
CN108148114B (zh) * | 2017-12-08 | 2020-05-15 | 珠海冀百康生物科技有限公司 | 一种提高重组小分子蛋白表达量的串联前导肽及方法 |
CN108929370B (zh) * | 2018-07-15 | 2021-06-25 | 渤海大学 | 三种具有ace抑制活性的鸡蛋源活性肽 |
EP3852873A1 (en) | 2018-09-19 | 2021-07-28 | Ziylo Ltd | Glucose sensitive insulins and uses thereof |
CN113773392B (zh) * | 2020-06-09 | 2023-04-07 | 宁波鲲鹏生物科技有限公司 | 一种甘精胰岛素的制备方法 |
WO2022090448A1 (en) | 2020-10-30 | 2022-05-05 | Novo Nordisk A/S | Novel acylating reagents |
WO2023144240A1 (en) | 2022-01-26 | 2023-08-03 | Novo Nordisk Research Centre Oxford Limited | Glucose sensitive insulin derivatives and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK58285D0 (da) * | 1984-05-30 | 1985-02-08 | Novo Industri As | Peptider samt fremstilling og anvendelse deraf |
WO1995016708A1 (en) * | 1993-12-17 | 1995-06-22 | Novo Nordisk A/S | Proinsulin-like compounds |
KR0150565B1 (ko) * | 1995-02-15 | 1998-08-17 | 김정재 | 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법 |
-
2000
- 2000-12-04 WO PCT/DK2000/000665 patent/WO2001049742A1/en active IP Right Grant
- 2000-12-04 CA CA2392840A patent/CA2392840C/en not_active Expired - Fee Related
- 2000-12-04 AT AT00981169T patent/ATE397017T1/de not_active IP Right Cessation
- 2000-12-04 HU HU0203475A patent/HUP0203475A3/hu unknown
- 2000-12-04 ES ES00981169T patent/ES2307544T3/es not_active Expired - Lifetime
- 2000-12-04 BR BR0016867-0A patent/BR0016867A/pt not_active Application Discontinuation
- 2000-12-04 RU RU2002120512/13A patent/RU2283846C2/ru not_active IP Right Cessation
- 2000-12-04 AU AU18506/01A patent/AU1850601A/en not_active Abandoned
- 2000-12-04 JP JP2001550282A patent/JP4773023B2/ja not_active Expired - Fee Related
- 2000-12-04 CN CNB008179603A patent/CN100432104C/zh not_active Expired - Lifetime
- 2000-12-04 DE DE60039074T patent/DE60039074D1/de not_active Expired - Lifetime
- 2000-12-04 EP EP00981169A patent/EP1246845B1/en not_active Expired - Lifetime
- 2000-12-04 KR KR1020027008588A patent/KR20030004317A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE397017T1 (de) | 2008-06-15 |
RU2002120512A (ru) | 2004-01-27 |
CA2392840A1 (en) | 2001-07-12 |
HUP0203475A2 (hu) | 2003-02-28 |
EP1246845B1 (en) | 2008-05-28 |
WO2001049742A1 (en) | 2001-07-12 |
DE60039074D1 (de) | 2008-07-10 |
PL355871A1 (en) | 2004-05-31 |
RU2283846C2 (ru) | 2006-09-20 |
KR20030004317A (ko) | 2003-01-14 |
HUP0203475A3 (en) | 2005-11-28 |
CN1414974A (zh) | 2003-04-30 |
JP4773023B2 (ja) | 2011-09-14 |
CA2392840C (en) | 2012-07-17 |
AU1850601A (en) | 2001-07-16 |
JP2003518945A (ja) | 2003-06-17 |
EP1246845A1 (en) | 2002-10-09 |
ES2307544T3 (es) | 2008-12-01 |
CN100432104C (zh) | 2008-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0016867A (pt) | Precursor de análogo de insulina, sequência de polinucleotìdeo, vetor de expressão, célula hospedeira, e, processos para fabricar um precursor de análogo de insulina e para fabricar um análogo de insulina | |
DK0720482T3 (da) | Prosaposin og cytokin-afledte peptider som terapeutiske midler | |
BR9712348A (pt) | molécula de polinucleotídeo isolada, vetor de expressão, célula cultivada em que foi introduzido um vetor de expressão, processo para produzir um polipeptídeo homólogo de fgf, polipeptídeo homólogo de fgf isolado,composição farmacêutica, anticorpo, processos para estimular ex vivo células progenitoras de miócitos, e, paraliberar um agente ou droga seletivamente para o tecido do coração. | |
ES2126743T3 (es) | Alfa-amilasa oxidativamente estable. | |
ATE177757T1 (de) | Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17 | |
ATE293696T1 (de) | Mutierte alpha-amylase enzyme mit erhöhter stabilität | |
MD960317A (ro) | Noile peptide-agoniste ale amilinei şi utilizarea lor | |
AU2003264419A1 (en) | Kdr peptides and vaccines containing the same | |
BR0009362A (pt) | Variante de uma alfa-amilase semelhante atermamyl precursora, construção de dna, vetorde expressão recombinante, célula, composição,processo para gerar uma variante de umaalfa-amilase semelhante a termamyl precursora,e, uso de uma variante de alfa-amilase | |
NO174351C (no) | Fremgangsmåte for fremstilling av human insulinforlöper samt DNA-sekvens og vektor til anvendelse av fremgangsmåten | |
HUP9900878A2 (hu) | Alfa-hordotionin nagy metionintartalmú származéka | |
BR9910639A (pt) | Drogas anti-angiogênicas compreendendo peptìdeo | |
BG101408A (en) | Analogs of keratinocyte growth factor | |
WO1998058957A3 (en) | Disulfide cross-linked glycoprotein hormone analogs, their preparation and use | |
CA2182795A1 (en) | Superactive vip antagonists | |
NO971621L (no) | Keratinocyttvekstfaktoranaloger | |
BG104161A (en) | Recombinant expression of insulin c-peptide | |
YU41798A (sh) | Scf analogni preparati i postupci | |
Rosenfeld et al. | Putative folding pathway of insulin-like growth factor-I | |
NO971508L (no) | Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet | |
Howard et al. | Iron-sulfur clusters and cysteine distribution in a ferredoxin from Azotobactervinelandii | |
BRPI0107708A8 (pt) | Vetor de expressão e secreção para interferon alfa humano e processo para produzir interferon alfa humano empregando o mesmo | |
HUP0101715A2 (hu) | Eljárások és készítmények reumatoid artritisz kezelésére | |
AU3473999A (en) | Injectable igf-formulations containing succinate as buffering agent | |
WO1989001490A3 (en) | Biologically active molecules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] |
Free format text: ANULADA A PUBLICACAO 7.4 NOTIFICADA NA RPI NO 2234, DE 29/10/2013, POR TER SIDO INDEVIDA. |
|
B10A | Cessation: cessation confirmed |